Turgut İlaçları A.Ş. is a Turkish pharmaceutical company engaged in developing, manufacturing, and commercializing biotechnological medicines, as well as commercializing high-technology small molecules.
The company was established in 1959 as Fako İlaçları A.Ş. and was one of the leaders in Turkey’s pharmaceutical sector for approximately sixty years. The company reorganized under the name Turgut İlaçları A.Ş. in 2006 and began investing in biotechnology after establishing Turgut Biotechnology Group in 2014.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company states its aim is to develop, manufacture, and market biotechnology products for Turkish and global markets, using biotechnology infrastructure in Turkey designed to international standards.
Source: LinkedIn company description · Retrieved October 13, 2026
The company is engaged in commercializing high-technology small molecules, alongside its biotechnological medicine activities.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 13, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 27, 2026, October 7, 2026 and October 9, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.